Canonical ingredient
cefprozil
CEFPROZIL
12 linked products
Official identifiers
CAS 92665-29-7ChEBI CHEBI:3506InChI InChI=1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1InChIKey WDLWHQDACQUCJR-PBFPGSCMSA-NKEGG_COMPOUND C06888NHPID_ID 5085SMILES [H][C@]12SCC(C=CC)=C(C(=O)O)N1C(=O)[C@@]2([H])NC(=O)[C@H](N)c1ccc(O)cc1
Names and synonyms
- cefprozil (en)
- Cefprozil (fr)
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
APO-CEFPROZIL
125 · MG · 5 · ML
APO-CEFPROZIL
250 · MG · 5 · ML
AURO-CEFPROZIL
250 · MG
AURO-CEFPROZIL
500 · MG
AVA-CEFPROZIL
250 · MG
AVA-CEFPROZIL
500 · MG
CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML
125 · MG · 5 · ML
CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML
250 · MG · 5 · ML
CEFZIL TABLETS - 250MG
250 · MG
CEFZIL TABLETS - 500MG
500 · MG
SANDOZ CEFPROZIL
250 · MG
SANDOZ CEFPROZIL
500 · MG